The vascular system forms through a combination of vasculogenesis and angiogenesis.
and spleen as well as the heart tube and dorsal aorta (1) . In the process of angiogenesis, small blood vesselsform by budding and sprouting from larger, extant vessels. Tissues of ectodermal and mesodermal derivation such as the kidney and brain are thought to he vascularized primarily via angiogenesis.
There is some controversy regarding vascularization of the retina. Since the retina is an extension of the brain, it was expected that, like the brain, it would be vascularized by angiogenesis. However, using immunohistochemical methods to visualize the vasculature, the presence of angioblast-like cells was documented in the developing dog retina (2) .
Common toboth angiogenesisand vasculogenesis is the process of remodeling.
Remodeling is a poorly understood event that includes growth of new vessels and the regression of others. Vascular remodeling involves changes in lumen diameter and vessel wall thickness to suit the local tissue needs. Thus, the vasculature often begins as a plexus of primitive capillary tubes ( Fig. 1 ) that is subsequently modified to generate the more complex vascular network of the adult (Fig. 2) .
The process of vascularization, whether by angiogenesis or by vasculogenesis, can be examined in a number of contexts.
Although there are several fundamental differences between angiogenesis and vasculogenesis, these two processes also share a number of regulatory features. Many excellent reviews have been written approaching the subject from a variety of perspectives, including tumor biology and wound healing (e.g., see ref 3) . The earliest context in which this subject can be examined is during embryonic development, and it is in this context that the molecular regulation of angiogenesis and vasculogenesis will be examined in this review.
Until recently, information regarding the regulation of angiogenesis and vasculogenesis was largely descriptive and came from classic embryologic studies. For instance, chick-quail grafting systems were used to demonstrate that many mesodermal tissues harbor cells capable of differentiating into EC, whereas ectoderm-derived tissues such as the neural tube or neural crest do not (4 (11) . The networks of vessels in the yolk sac, the dorsal aortae, and other smaller vessels are all absent, confirming the absolute requirement for Flk-1 in the growth and/or establishment of the endothelial lineage. Flt-1 null mice also display embryonic lethality between E8.5 and E9.5 (12) . These embryos have a grossly abnormal vasculature, but the defect appears to lie more in the organization of EC into tubelike structures than in the differentiation of the endothelium itself. Instead of surrounding a core of hematopoietic precursors as a monolayer, the EC of the yolk sac blood islands in Flk-1 null mice are disorganized and are present as aggregates and sheets within the lumen. Embryonic vessels such as the dorsal aortae, which arise by vasculogenesis, and the small vessels in the head mesenchyme, which form via angiogenesis, display a similar phenotype, with internally located EC.
Animals deficient in VEGF have been generated by two independent laboratories and, somewhat surprisingly, reveal embryonic lethality in the heterozygous state (13, 14) . The heterozygous mutant embryos die in utero between
Eli and E12, and are characterized by defects in most of the early processes in vessel formation. These results suggest that VEGF exerts a dose-dependent effect during formation of the vasculature.
Strict VEGF dose dependence is also suggested by studies that involve the overexpression of VEGF in developing avian embryos. Microinjection of VEGF16S into quail embryos, just before formation of the dorsal aortae and associated vascular plexus, led to the formation of a hyperfused network of vessels and the development of vessels in areas that are usually avascular (15) . In another series of experiments, introduction of VEGF-expressing retroviruses into the developing chick limb bud resulted in local increases in vascular density, with no other phenotypic abnormalities (16) . In light of the apparent sensitivity of the developing vascular system to VEGF (as reflected by the lethality of the embryos heterozygous for VEGF), the different outcomes in these two studies are likely due to local differences in VEGF concentrations.
A series of studies has provided strong evidence in support of a role for hypoxic regulation of VEGF in retinal vascularization.
Astrocytes that migrate into developing feline or murine retinas express elevated levels of VEGF, presumably in response to local "physiologic" hypoxia created by the rapidly differentiating neural elements (17) . Once the retinal tissue is vascularized and the oxygen demand is met, the astrocyte production of VEGF is reduced. These observations have led to a viable explanation for an ocular pathology called retinopathy of prematurity in which excess oxygen leads to "vaso-obliteration" in the developing retinas of premature infants (18) . It is speculated that the therapeutic oxygen administered to the premature infants leads to a down-regulation of VEGF, and thus interferes with the normal vascularization of the retina. Once the child is returned to room air, the retina experiences "relative hypoxia" and VEGF synthesis is induced, as has been shown in ischemic models (19) (20) . In addition, the light micrographs in this report failed to provide resolution of the smaller vessels that was sufficient to determine whether the PDGF 
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Receptors
The Tie receptors comprise a second class of receptor tyrosine kinases, in addition to receptors for VEGF, that appear to be specific for vascular endothelium. tie-i mRNA is first detected in the mouse at E8.5 in angioblasts of the head mesenchyme, in EC of the dorsal aortae, and in blood islands of the yolk sac (45) . Expression of tie-i mRNA in vascular endothelium continues throughout embryogenesis,but in the adult animal expressionislimited to capillaries in the perialveolar septa of the lung. Studies with Tie-i-deficient animals suggest that Tie-i is important for EC differentiation as well as for the establishment of vessel integrity (46) . Tie-i null embryos die perinatally due to breathing difficulties, and display marked subcutaneous as well as internal hemorrhages and edema. Although the general vascular patterning is normal in these animals, ultrastructural analyses reveal that the vascular defect lies in the overall integrity of the EC. Capillary EC of Tie-i -Iembryos appear "electron light" with respect to their wild-type counterparts, and despite apparently intact cell-cell junctions, red blood cells were observed to extravasate through the endothelium. tie-i mRNA has been shown to be up-regulated in endothelium of two types of abnormal vessels, including the pericyte-deficient capillaries of PDGF-B -Imice (C. Betsholtz, personal communication, and P. Lindahl, unpublished results) and the endothelium of certain vascular malformations (47) . Tiei-deficient animals were also generated by another group; in this case, the homozygous mutant embryos died at E14.5 with extensive hemorrhages and abdominal edema (48) . The difference in the time of death between the two Tie-i null lines of mice may be due to differences in genetic background.
The ability of Tie-i-deficient EC to contribute to the vasculature was assessed by creating chimeras from wildtype morulas and embryonic stem cells in which the tie-i allele had been disrupted with a lacZ reporter construct (49) . At EiO.5, Tie-i-deficient cells contributed to all vessels in the embryos.
In contrast, at E15.5, although the mutant cells were still found in many vessels, such as those of the heart and lung, they were underrepresented in vessels derived from angiogenic processes, such as those from the midbrain and kidney. In the adult there appeared to be further selection against the Tie-i-deficient EC, as none were found in the kidney, and there were reduced numbers in the vasculature of the lung. These results suggest a differential requirement for Tie-i in vascular beds derived by vasculogenesis vs. angiogenesis. Tie-2 (also known as Tek) is the second member of the family. It is detected first in the developing mouse embryo in the vasculature of the E7.5 yolk sac. tie-2 mRNA is detected in E8.0 embryos in the endocardium, in the dorsal aortae, in maternal decidual blood vessels, and in the yolk sac vasculature (50) . Very little tie-2 mRNA is detected in the endothelium of adult animals, although a strong signal was obtained with adult heart tissue by Northern blot analysis.
Two approaches have been taken to eliminate Tie-2 function.
Using a transgenic approach, a dominant negative Tie-2 was expressed under the control of a 7.2 kb tie-2 promoter.
Although the authors report that the mutant receptor displayed no kinase activity when expressed in vitro, the animals showed a variable, apparently nonspecific phenotype (51) . In the same study, the authors deleted the translation start site and signal peptide to create Tie-2-deficient mice. The homozygous mutant embryos were all dead by E9.5, and displayed engorged and distended yolk sac vessels at E8.5. The dorsal aorta was ruptured and disorganized, and the hearts did not possess organized trabeculae.
The authors note a general deficiency of EC. In an independent line of Tie-2 null mice (in which the tie-2 gene was disrupted in the second exon), all homozygous null embryos were dead at EiO.5, with a mild growth retardation (especially in the head and heart) apparent by E9.5 (46) . The most prominent abnormalities in the mutant embryos were in the vasculature.
There was little distinction between large and small vessels in the brain, suggesting a defect in vascular remodeling.
In addition, the angiogenic capillary sprouts that usually protrude into the neuroectoderm were absent in the Tie-2 null embryos.
Tie-2 ligands
Ligands for Tie-2 have recently been identified and have been named angiopoietins (52) . Angiopoietin-i is an activating ligand (i.e., it promotes tyrosine phosphorylation of the receptor). There is also an inhibitory ligand, angiopoietin-2, that apparently antagonizes the action of angiopoietin-1 (G. D. Yancopoulos, personal communication). Angiopoietin-i is first expressed between E9 and Eli, most prominently in the heart myocardium surrounding the endocardium.
Later in development the transcript is found more widely throughout the embryo, often associated with the mesenchyme adjacent to developing vessels. Angiopoietin-i-deficient mice have a phenotype similar to the Tie-2 -/-mice (53). The angiopoietin-i null embryos die at Ei2.5 (ito 2 days later than the Tie-2 null embryos), and the most profound defects are in the heart where the endocardium and trabecular network are very immature. Similar to the Tie-2-deficient mice, the primary vascular plexus in the angiopoietin-i null animals does not fully remodel into large and small caliber vessels. A clue to the cellular basis of this remodeling defect comes from ultrastructural studies (53) . In wild-type animals, existing vessels are split by "tissue folds" that contain organized collagen fibers and pericyte-like cells intimately associated with the endothelium.
The tissue folds in the angiopoietin-1 null animals, by contrast, are less extensive, lack these pericytes, and contain scattered, disorganized collagen fibers. The EC in these areas are particularly rounded and appear to have defective interactions with the underlying matrix. Recently, a dominantly inherited venous malformation has been mapped to the tie-2 locus (54). A single amino acid change has been found to lead to a 6-to iO-fold increase in autophosphorylation in a recombinantly expressed mutant receptor. The phenotype of the venous malformations is notable in that the vessels are dilated and display a paucity of SMC. The investigators hypothesize that the activating receptor mutation leads to a down-regulation of angiopoietin-i expression in the mesenchymal cells and, through an intracellular coupling pathway, to their decreased migration, proliferation, and differentiation. Another possibility is that angiopoietin-i normally induces the EC to release factors chemotactic for mesenchymal cells, but in the Tie-2 mutant cells the receptor is not truly activated in a physiological sense, so that this recruitment pathway is defective (55) .
COAGULATION FACTORS
Although the nature of their involvement is unclear, intriguing observations have also been made that link the coagulation factors to vascular development. Observations in mice with targeted disruption of the tissue factor (TF) and factor V gene, two proteins involved in coagulation, have led to the suggestion that these molecules may play a role in vessel formation.
Tissue factor
TF, a high-affinity receptor and cofactor for factor VII/ VIIa, is the main cell-associated initiator of coagulation. Absence of TF leads to embryonic lethality between E9.5 and El0.5 (56) 
Factor V
Coagulation factor V has also been implicated in vasculogenesis,although the evidence to support this is less compelling than that for TF. About 50% of mice deficient for factor V die in utero between E9 and ElO due to abnormal development of the yolk sac vasculature (58) . The remaining mice develop to term but die at birth, the result of massive hemorrhage.
There are no data regarding the action of factor V on vascular cells outside of the coagulation pathway. However, the embryonic lethality of half of the embryos is similar to that observed in mice lacking the thrombin receptor, where 50% of the embryos die at E9.5 in the absence of any coagulation defects (59). Together, these results suggest that factor V-dependent generation of thrombin and its action through the thrombin receptor are necessary in early development and possibly during yolk sac vasculogenesis.
THE INTEGRIN cxf33
Vessel development, whether it be by vasculogenesis or angiogenesis, requires the migration of EC, a process that involves the function of cell adhesion molecules such as integrins.
a433, an integrin expressed by EC, has been implicated in angiogenesis.
Newly formed blood vessels in the granulation tissue of a healing cutaneous wound were found to express this integrin, whereas established vessels in normal skin were negative (60) . This finding was later extended in studies in which a433was localized to the tips of the EC in sprouting vessels (61) . As the vessels matured, the a433expression diminished to a level undetectable by immunohistochemistry.
Perhaps more important, the function of the a,133inte-grin appears to be critical for the formation and/or maintenance of the newly formed vessels. Inclusion of a neutralizing monoclonal antibody specific for c133 in an angiogenesis assay on the chick chorioallantoic membrane led to the inhibition of neovascularization induced by bFGF and by human melanoma fragments (60); antibodies against a435, a related integrmn, had no effect. Blocking a133 had no apparent effect on the preexisting vessels of the chick chorioallantoic membrane, an observation that is consistent with the absence of a433 immunoreactivity in mature, quiescent vessels. Subsequent work has suggested that interfering with the interaction of the a.133integrin
and its natural substrates (e.g. fibrin, fibronectin, vitronectin) induces apoptosis in the proliferating EC of the nascent vessels (62) .
The role of a133 in vasculogenesis has been addressed by microinjection of neutralizing antibodies into the developing quail embryo (63) . In these embryos, the dorsal aortae, although positioned correctly, failed to form patent lumens. In addition, treated embryos displayed disconti-
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It is also interesting to consider whether angiostatin, an endogenous inhibitor of angiogenesis that has been shown to be derived from plasminogen (67) , may block with vessel formation by interfering with these pathways.
CONCLUDING REMARKS
Significant progress has been made in our understanding of the development of the vasculature, which has as its foundation descriptive yet elegant classical embryological studies. With the ability to culture vascular cells in vitro and the elucidation of defined molecules important in vascular cell growth and function, a new era of vascular biology began. Many factors critical to vascular development and regulation have been discovered and/or better characterized via analysis of genetically altered mice. Future studies will build on this current base of knowledge by addressing poorly understood areas such as vascular remodeling, signaling pathways transduced by endothelialspecific receptors, and the regulation of vascular cell differentiation, to name a few.
